A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 974,653 shares of SPRO stock, worth $1.28 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
974,653
Previous 975,952 0.13%
Holding current value
$1.28 Million
Previous $1.27 Million 3.0%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$1.19 - $1.5 $1,545 - $1,948
-1,299 Reduced 0.13%
974,653 $1.31 Million
Q2 2024

Aug 09, 2024

BUY
$1.27 - $1.8 $154,294 - $218,685
121,492 Added 14.22%
975,952 $1.27 Million
Q1 2024

May 13, 2024

BUY
$1.35 - $1.79 $414,443 - $549,521
306,995 Added 56.08%
854,460 $1.47 Million
Q4 2023

Feb 13, 2024

BUY
$1.0 - $1.47 $300 - $441
300 Added 0.05%
547,465 $805,000
Q3 2023

Nov 14, 2023

SELL
$1.2 - $1.63 $55,519 - $75,413
-46,266 Reduced 7.8%
547,165 $662,000
Q2 2023

Aug 11, 2023

BUY
$1.42 - $1.95 $260,046 - $357,105
183,131 Added 44.63%
593,431 $860,000
Q1 2023

May 12, 2023

BUY
$1.35 - $2.0 $90,990 - $134,800
67,400 Added 19.66%
410,300 $595,000
Q4 2022

Feb 13, 2023

BUY
$1.55 - $2.12 $198,710 - $271,784
128,200 Added 59.71%
342,900 $593,000
Q3 2022

Nov 14, 2022

SELL
$0.68 - $2.2 $492,535 - $1.59 Million
-724,317 Reduced 77.14%
214,700 $429,000
Q2 2022

Aug 12, 2022

BUY
$0.74 - $7.44 $614,138 - $6.17 Million
829,917 Added 760.69%
939,017 $696,000
Q1 2022

May 13, 2022

BUY
$7.87 - $15.15 $858,617 - $1.65 Million
109,100 New
109,100 $949,000
Q4 2020

Feb 10, 2021

SELL
$11.65 - $22.07 $1.78 Million - $3.38 Million
-153,203 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$8.96 - $14.12 $1.58 Million - $2.5 Million
-176,700 Reduced 53.56%
153,203 $1.71 Million
Q2 2020

Aug 13, 2020

BUY
$7.27 - $14.18 $40,712 - $79,408
5,600 Added 1.73%
329,903 $4.46 Million
Q1 2020

May 14, 2020

SELL
$5.27 - $10.41 $73,253 - $144,699
-13,900 Reduced 4.11%
324,303 $2.62 Million
Q4 2019

Feb 13, 2020

BUY
$9.46 - $12.16 $807,884 - $1.04 Million
85,400 Added 33.78%
338,203 $3.25 Million
Q3 2019

Nov 13, 2019

BUY
$9.01 - $12.55 $341,479 - $475,645
37,900 Added 17.64%
252,803 $2.68 Million
Q2 2019

Aug 12, 2019

BUY
$10.25 - $14.36 $1.04 Million - $1.46 Million
101,600 Added 89.67%
214,903 $2.47 Million
Q1 2019

May 14, 2019

BUY
$6.26 - $13.31 $440,704 - $937,024
70,400 Added 164.09%
113,303 $1.45 Million
Q4 2018

Feb 13, 2019

BUY
$5.69 - $11.28 $244,118 - $483,945
42,903 New
42,903 $264,000

Others Institutions Holding SPRO

About Spero Therapeutics, Inc.


  • Ticker SPRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,067,500
  • Market Cap $45.9M
  • Description
  • Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...
More about SPRO
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.